Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BioPsychoSocial Medicine
Published in: BioPsychoSocial Medicine 1/2016

Open Access 01-12-2016 | Review

Psychosomatic problems in dentistry

Author: Akira Toyofuku

Published in: BioPsychoSocial Medicine | Issue 1/2016

Login to get access

Abstract

Many dental patients complain of oral symptoms after dental treatment, such as chronic pain or occlusal discomfort, for which the cause remains undetermined. These symptoms are often thought to be mental or emotional in origin, and patients are considered to have an “oral psychosomatic disorder”. Representative medically unexplained oral symptoms/syndromes (MUOS) include burning mouth syndrome, atypical odontalgia, phantom bite syndrome, oral cenesthopathy, or halitophobia. With an increasing prevalence of these MUOS, dentists are being asked to develop new approaches to dental treatment, which include taking care of not only the patient’s teeth but also the patient’s suffering. Progress in the understanding of mind-body interactions will lead to investigations on the pathophysiology of MUOS and the development of new therapeutic approaches.
Literature
1.
Leon-Salazar V, Morrow L, Schiffman EL. Pain and persistent occlusal awareness: what should dentists do? J Am Dent Assoc. 2012;143(9):989–91. PubMed PMID: 22942145; PubMed Central PMCID: PMC4526237.CrossRefPubMedPubMedCentral
2.
Toyofuku A. From psychosomatic dentistry to brain dentistry. Kokubyo Gakkai Zasshi. 2007;74(3):161–8. Review. (in Japanese). PubMed PMID: 18027579.CrossRefPubMed
3.
4.
5.
Grushka M, Epstein M, Gorsky M. Burning mouth syndrome. Am Fam Physician. 2002;65(4):615–21.PubMed
6.
7.
Barros Vde M, Seraidarian PI, Côrtes MI, de Paula LV. The impact of orofacial pain on the quality of life of patients with temporomandibular disorder. J Orofac Pain. 2009;23(1):28–37. PubMed PMID: 19264033.PubMed
8.
Durham J, Nixdorf DR. Healthcare pathway and biopsychosocial impact of persistent dentoalveolar pain disorder: a qualitative study. Int Endod J. 2014;47(12):1151–9. doi:10.​1111/​iej.​12263. Epub 2014 Mar 20. PubMed PMID: 24697333.CrossRefPubMed
9.
Davies SJ, Underhill HC, Abdel-Karim A, Christmas DM, Bolea-Alamanac BM, Herrod J, Prime SS. Individual oral symptoms in burning mouth syndrome may be associated differentially with depression and anxiety. Acta Odontol Scand. 2015;23:1–6. [Epub ahead of print] PubMed PMID: 26494262.
10.
Adamo D, Celentano A, Ruoppo E, Cucciniello C, Pecoraro G, Aria M, Mignogna MD. The relationship between sociodemographic characteristics and clinical features in burning mouth syndrome. Pain Med. 2015. doi:10.​1111/​pme.​12808. [Epub ahead of print] PubMed PMID: 26301724.
11.
Takenoshita M, Sato T, Kato Y, Katagiri A, Yoshikawa T, Sato Y, Matsushima E, Sasaki Y, Toyofuku A. Psychiatric diagnoses in patients with burning mouth syndrome and atypical odontalgia referred from psychiatric to dental facilities. Neuropsychiatr Dis Treat. 2010;6:699–705. doi:10.​2147/​NDT.​S12605. PubMed PMID: 21127687; PubMed Central PMCID: PMC2987502.
12.
Valença MM, de Oliveira DA, Martins HA. Alice in Wonderland syndrome, burning mouth syndrome, cold stimulus headache, and HaNDL: narrative review. Headache. 2015;55(9):1233–48. doi:10.​1111/​head.​12688. Epub 2015 Sep 30. PubMed PMID:26422755.CrossRefPubMed
13.
14.
Mignogna MD, Fedele S, Lo Russo L, Leuci S, Lo Muzio L. The diagnosis of burning mouth syndrome represents a challenge for clinicians. J Orofac Pain. 2005;19(2):168–73. PMID: 15895840.PubMed
15.
Mignogna MD, Pollio A, Fortuna G, Leuci S, Ruoppo E, Adamo D, Zarrelli C. Unexplained somatic comorbidities in patients with burning mouth syndrome: a controlled clinical study. J Orofac Pain. 2011;25(2):131–40. PubMed PMID: 21528120.
16.
Kolkka-Palomaa M, Jääskeläinen SK, Laine MA, Teerijoki-Oksa T, Sandell M, Forssell H. Pathophysiology of primary burning mouth syndrome with special focus on taste dysfunction: a review. Oral Dis. 2015;21(8):937–48. doi:10.​1111/​odi.​12345. Epub 2015 Jun 25. Review. PubMed PMID: 25962669.CrossRefPubMed
17.
Yoshikawa T, Toyofuku A. Psychopharmacology and oral psychosomatic disorder. Nihon Rinsho. 2012;70(1):122–5. Review. Japanese. PubMed PMID: 22413505.PubMed
18.
Kato Y, Sato T, Katagiri A, Umezaki Y, Takenoshita M, Yoshikawa T, Sato Y, Toyofuku A. Milnacipran dose-effect study in patients with burning mouth syndrome. Clin Neuropharmacol. 2011;34(4):166–9. doi:10.​1097/​WNF.​0b013e318227f100​. PubMed PMID: 21738023.
19.
Yamazaki Y, Hata H, Kitamori S, Onodera M, Kitagawa Y. An open-label, noncomparative, dose escalation pilot study of the effect of paroxetine in treatment of burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107(1):e6–11. doi:10.​1016/​j.​tripleo.​2008.​08.​024. Epub 2008 Nov 8. PubMed PMID: 18996028.CrossRefPubMed
20.
Forssell H, Jääskeläinen S, List T, Svensson P, Baad-Hansen L. An update on pathophysiological mechanisms related to idiopathic oro-facial pain conditions with implications for management. J Oral Rehabil. 2015;42(4):300–22. doi:10.​1111/​joor.​12256. Epub 2014 Dec 8. Review. PubMed PMID: 25483941.CrossRefPubMed
21.
Khan SA, Keaser ML, Meiller TF, Seminowicz DA. Altered structure and function in the hippocampus and medial prefrontal cortex in patients with burning mouth syndrome. Pain. 2014;155(8):1472–80. doi:10.​1016/​j.​pain.​2014.​04.​022. Epub 2014 Apr 24. PubMed PMID: 24769366.CrossRefPubMed
22.
Umezaki Y, Badran BW, DeVries WH, Moss J, Gonzales T, George MS. The efficacy of daily prefrontal repetitive transcranial magnetic stimulation (rTMS) for burning mouth syndrome (BMS): a randomized controlled single-blind study. Brain Stimul. 2015. doi:10.​1016/​j.​brs.​2015.​10.​005. [Epub ahead of print] PubMed PMID: 26597930.PubMed
23.
24.
Katagiri A, Shinoda M, Honda K, Toyofuku A, Sessle BJ, Iwata K. Satellite glial cell P2Y12 receptor in the trigeminal ganglion is involved in lingual neuropathic pain mechanisms in rats. Mol Pain. 2012;8:23. doi:10.​1186/​1744-8069-8-23. PubMed PMID: 22458630; PubMed Central PMCID: PMC3386019.CrossRefPubMedPubMedCentral
25.
Shinoda M, Takeda M, Honda K, Maruno M, Katagiri A, Satoh-Kuriwada S, Shoji N, Tsuchiya M, Iwata K. Involvement of peripheral artemin signaling in tongue pain: possible mechanism in burning mouth syndrome. Pain. 2015;156(12):2528–37. doi:10.​1097/​j.​pain.​0000000000000322​. PubMed PMID: 26270588.
26.
27.
28.
Jagger RG, Korszun A. Phantom bite revisited. Br Dent J. 2004;197(5):241–3. PubMed PMID: 15359317.CrossRefPubMed
29.
30.
31.
Watanabe M, Umezaki Y, Suzuki S, Miura A, Shinohara Y, Yoshikawa T, Sakuma T, Shitano C, Katagiri A, Sato Y, Takenoshita M, Toyofuku A. Psychiatric comorbidities and psychopharmacological outcomes of phantom bite syndrome. J Psychosom Res. 2015;78(3):255–9. doi:10.​1016/​j.​jpsychores.​2014.​11.​010. Epub 2014 Nov 15. PubMed PMID: 25477300.
32.
Toyofuku A. A clinical study on psychosomatic approaches in the treatment of serious oral psychosomatic disorders during hospitalization - evaluation of “behavior restriction therapy” for oral psychosomatic disorders and consideration of its pathophysiology. Jpn J Psychosom Dent. 2000;15(1):41–72 (in Japanese).
33.
Toyofuku A, Kikuta T. Treatment of phantom bite syndrome with milnacipran–a case series. Neuropsychiatr Dis Treat. 2006;2(3):387–90. PubMed PMID:19412487; PubMed Central PMCID: PMC2671812.CrossRefPubMedPubMedCentral
34.
Umezaki Y, Watanabe M, Takenoshita M, Yoshikawa T, Sakuma T, Sako E, Katagiri A, Sato Y, Toyofuku A. A case of phantom bite syndrome ameliorated with the attenuation of the asymmet- rical pattern of regional cerebral blood flow. Jpn J Psychosom Dent. 2013;28:30–4 (in Japanese).
35.
36.
Umezaki Y, Katagiri A, Watanabe M, Takenoshita M, Sakuma T, Sako E, Sato Y, Toriihara A, Uezato A, Shibuya H, Nishikawa T, Motomura H, Toyofuku A. Brain perfusion asymmetry in patients with oral somatic delusions. Eur Arch Psychiatry Clin Neurosci. 2013;263(4):315–23. doi:10.​1007/​s00406-013-0390-7. Epub 2013 Jan 29. PubMed PMID: 23354990; PubMed Central PMCID: PMC3668126.
37.
Watanabe M, Umezaki Y, Miura A, Shinohara Y, Yoshikawa T, Sakuma T, Shitano C, Katagiri A, Takenoshita M, Toriihara A, Uezato A, Nishikawa T, Motomura H, Toyofuku A. Comparison of cerebral blood flow in oral somatic delusion in patients with and without a history of depression: a comparative case series. BMC Psychiatry. 2015;15:42. doi:10.​1186/​s12888-015-0422-0. PubMed PMID:25886053; PubMed Central PMCID: PMC4364484.
38.
Uezato A, Yamamoto N, Kurumaji A, Toriihara A, Umezaki Y, Toyofuku A, Nishikawa T. Improvement of asymmetrical temporal blood flow in refractory oral somatic delusion after successful electroconvulsive therapy. J ECT. 2012;28(1):50–1. doi:10.​1097/​YCT.​0b013e31822e581e​. PubMed PMID: 21983760.
39.
Uezato A, Toyofuku A, Umezaki Y, Watanabe M, Toriihara A, Tomita M, Yamamoto N, Kurumaji A, Nishikawa T. Oral Dysesthesia Rating Scale: a tool for assessing psychosomatic symptoms in oral regions. BMC Psychiatry. 2014;14:1696. doi:10.​1186/​s12888-014-0359-8. PubMed PMID: 25528456; PubMed Central PMCID:PMC4300025.
40.
41.
42.
43.
Toyofuku A, Umemoto G, Miyagi T, Tone K, Kikuta T, Miyako H. The efficacy of fluvoxamine for “halitophobia”. Jpn J Psychosom. 2001;16(1):81–5.
44.
Peciña M, Bohnert AS, Sikora M, Avery ET, Langenecker SA, Mickey BJ, Zubieta JK. Association between placebo-activated neural systems and antidepressant responses: neurochemistry of placebo effects in major depression. JAMA Psychiatry. 2015;72(11):1087–94. doi:10.​1001/​jamapsychiatry.​2015.​1335. PubMed PMID: 26421634.
45.
Schneider RK, Levenson JL. Psychiatry essentials for primary care. 1st ed. Philadelphia: American College of Physicians; 2007. p. 1–9.
Metadata
Title
Psychosomatic problems in dentistry
Author
Akira Toyofuku
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BioPsychoSocial Medicine / Issue 1/2016
Electronic ISSN: 1751-0759
DOI
https://doi.org/10.1186/s13030-016-0068-2

Other articles of this Issue 1/2016

BioPsychoSocial Medicine 1/2016 Go to the issue

Research

Depressive symptoms are associated with oxidative stress in middle-aged women: a cross-sectional study

Case report

A series of patients with purging type anorexia nervosa who do “tube vomiting”

Review

The meaning of behavioral medicine in the public health field—a review of documents related to medical education in Japan

Research

Factors relating to the mental health of women who were pregnant at the time of the Great East Japan earthquake: analysis from month 10 to month 48 after the earthquake

Research

Seasonality in mood and behaviours of Japanese residents in high-latitude regions: transnational cross-sectional study

Review

Special series on “The meaning of behavioral medicine in the psychosomatic field” establishment of a core curriculum for behavioral science in Japan: The importance of such a curriculum from the perspective of psychology